Literature DB >> 23072252

Adherent-invasive Escherichia coli blocks interferon-γ-induced signal transducer and activator of transcription (STAT)-1 in human intestinal epithelial cells.

Juan C Ossa1, Nathan K Ho, Eytan Wine, Nelly Leung, Scott D Gray-Owen, Philip M Sherman.   

Abstract

Adherent-invasive Escherichia coli (AIEC) is a pathogen isolated from the ileum of patients with Crohn disease. IFNγ is a key mediator of immunity, which regulates inflammatory responses to microbial infections. Previously, we showed enterohemorrhagic E. coli prevents STAT1 activation. The aim of this study was to determine whether activation of STAT1 by IFNγ was prevented by AIEC infection, and to define the mechanisms used. Human epithelial cells were infected with three different AIEC strains or other pathogenic and commensal E. coli strains. Following infection, cells were stimulated with IFNγ, and STAT1 activation was monitored by immunoblotting. Our data show that live AIEC with active protein synthesis machinery is able to prevent IFNγ-mediated STAT1 phosphorylation, and that a secreted factor may be involved. We conclude that the suppression of epithelial cell STAT1 signal transduction by AIEC strains isolated from patients with Crohn disease represents a novel mechanism by which the pathogen evades host immune responses to the infection.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23072252     DOI: 10.1111/cmi.12048

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  9 in total

Review 1.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 2.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  [Effect of eicosapentaenoic acid on mRNA expression of tight junction protein ZO-1 in intestinal epithelial cells after Escherichia coli LF82 infection].

Authors:  Li-Jun Hao; Yan Lin; Wei Zhang; Jiao Tian; Ya Wang; Peng-De Chen; Chong-Kang Hu; Ling-Chao Zeng; Jie Yang; Bao-Xi Wang; Xun Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-06

Review 4.  Changes of intestinal microbiota and microbiota-based treatments in IBD.

Authors:  Qianyu Li; Siyu Zhou; Yanna Wang; Jing Cong
Journal:  Arch Microbiol       Date:  2022-07-01       Impact factor: 2.552

5.  Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NFκB signaling.

Authors:  Khalidur Rahman; Maiko Sasaki; Asma Nusrat; Jan-Michael A Klapproth
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 6.  The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.

Authors:  Sheng Liu; Wenjing Zhao; Ping Lan; Xiangyu Mou
Journal:  Protein Cell       Date:  2020-06-29       Impact factor: 14.870

7.  Uropathogenic E. coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2).

Authors:  Kenneth Ting; Karen J Aitken; Frank Penna; Alaleh Najdi Samiei; Martin Sidler; Jia-Xin Jiang; Fadi Ibrahim; Cornelia Tolg; Paul Delgado-Olguin; Norman Rosenblum; Darius J Bägli
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 8.  Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.

Authors:  Jun-Hwan Yoo; Mark Donowitz
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.374

9.  A Novel Strategy to Study the Invasive Capability of Adherent-Invasive Escherichia coli by Using Human Primary Organoid-Derived Epithelial Monolayers.

Authors:  Aida Mayorgas; Isabella Dotti; Marta Martínez-Picola; Miriam Esteller; Queralt Bonet-Rossinyol; Elena Ricart; Azucena Salas; Margarita Martínez-Medina
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.